Local Institution - 0333 — Haverhill, Massachusetts

Local Institution - 0333 is a clinical research site located in Haverhill, Massachusetts, United States 01830.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0333 has participated in 1 clinical trials.

Therapeutic areas: Atrial Fibrillation, Atrial Flutter.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Haverhill

Browse all research sites in Massachusetts · View every site in Haverhill

• Lawrence General Hospital
• Pentucket Medical Associates
• Research Site
• GSK Investigational Site
• ActivMed Practices and Research
• East Coast Clinical Research
• ActivMed Practices & Research
• Dana Farber Community Cancer Care-Haverhill
• Novartis Investigative Site
• Pfizer Investigational Site
• Local Institution
• Forest Investigative Site 1726

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0333?

Local Institution - 0333 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0333 conducted?

Local Institution - 0333 has 1 clinical trials on record. Their work covers Atrial Fibrillation, Atrial Flutter.

Is Local Institution - 0333 accredited by Crixeo Clinical Trials?

Local Institution - 0333 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0333?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.